Yuko Kawasaki

Inhibition of HIV‐2 Protease by HIV‐1 Protease Inhibitors in Clinical Use

Evan T. Brower, Usman Bacha, Yuko Kawasaki et al. · Chemical Biology & Drug Design · 2008 · 109 citations

Medicine, Pharmacology, Pharmacotherapy +17

Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety

Sho Konno, Thanigaimalai Pillaiyar, Takehito Yamamoto et al. · Bioorganic & Medicinal Chemistry · 2012 · 84 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +11

Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure–activity relationship study

Thanigaimalai Pillaiyar, Sho Konno, Takehito Yamamoto et al. · European Journal of Medicinal Chemistry · 2013 · 69 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Genetic regulation mediated by thiamin pyrophosphate‐binding motif in <i>Saccharomyces cerevisiae</i>

Kazuto Nosaka, Mari Onozuka, Hiroyuki Konno et al. · Molecular Microbiology · 2005 · 48 citations

Life Sciences, Genetics, Molecular Biology +17

A constitutive thiamine metabolism mutation, thi80, causing reduced thiamine pyrophosphokinase activity in Saccharomyces cerevisiae

Hiroshi Nishimura, Yuko Kawasaki, Kazuto Nosaka et al. · Journal of Bacteriology · 1991 · 38 citations · Full text

Life Sciences, Genetics, Microbiology +15